Aethlon Medical, Inc. (AEMD)
NCM · Healthcare · Medical Devices
$1.53
-1.92%
Closing price as of 2026-09-11 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.1M
Shares Outstanding
711K
Exchange
NCM
Currency
USD
About Aethlon Medical, Inc.
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | |
| Operating Income | (1.5M) | (2.1M) | (1.9M) | |
| Net Income | (1.5M) | (2.0M) | (1.9M) | |
| Diluted EPS | $-37.40 | $-2.45 | N/A | $-4.02 |
Annual Financials
| Metric | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 574K | 0.00 | 0.00 | 0.00 |
| Operating Income | (11.9M) | (12.6M) | (9.3M) | (7.3M) |
| Net Income | (12.0M) | (12.2M) | (13.4M) | (7.2M) |
| Diluted EPS | $-47.20 | $-388.80 | $-85.77 | $-10.61 |